Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002685-70Phase 4Completed
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin arm with Placebo arm (2 arms). Primary endpoint: Primary: Effect of sitagliptin on glucagon counter-regulation to hypoglycemia. Started Aug 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002685-70.